Holdings of Sofinnova Investments, Inc.
51 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 60.7 % of the equity sleeve
Sector breakdown
- Health care 40.5 %
- Unattributed 59.5 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 50 | 1.6B $ | 98.77 % |
| 2 | DK | 1 | 20.2M $ | 1.23 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | Natera Inc | 1,550,280 | 310M $ | |
| 2 | Bristol-Myers Squibb Co | 1,988,721 | 120.6M $ | |
| 3 | Vera Therapeutics Inc | 2,793,987 | 112.4M $ | |
| 4 | United Therapeutics Corp | 160,070 | 94.9M $ | |
| 5 | Cogent Biosciences Inc | 2,113,551 | 81.4M $ | |
| 6 | Ultragenyx Pharmaceutical Inc | 3,145,888 | 65.9M $ | |
| 7 | Rapport Therapeutics Inc | 1,904,408 | 59.6M $ | |
| 8 | Insmed Inc | 346,075 | 56.6M $ | |
| 9 | Supernus Pharmaceuticals Inc | 954,309 | 49.3M $ | |
| 10 | BioMarin Pharmaceutical Inc | 781,982 | 44.2M $ | |
| 11 | Biogen Inc | 229,521 | 42.1M $ | |
| 12 | Celcuity Inc | 366,175 | 41.8M $ | |
| 13 | BioAge Labs Inc | 2,293,788 | 40.1M $ | |
| 14 | Rhythm Pharmaceuticals Inc | 450,096 | 39.1M $ | |
| 15 | ArriVent Biopharma Inc | 1,696,752 | 39.1M $ | |
| 16 | Ideaya Biosciences Inc | 1,131,786 | 37.7M $ | |
| 17 | Immunome Inc | 1,701,904 | 37.2M $ | |
| 18 | Nektar Therapeutics | 509,546 | 36.7M $ | |
| 19 | Axsome Therapeutics Inc | 212,747 | 36M $ | |
| 20 | Bridgebio Pharma Inc | 409,183 | 30.4M $ | |
| 21 | Dyne Therapeutics Inc | 1,633,897 | 29.6M $ | |
| 22 | Inhibrx Biosciences Inc | 406,029 | 27.3M $ | |
| 23 | Dexcom Inc | 393,576 | 24.7M $ | |
| 24 | Praxis Precision Medicines Inc | 63,680 | 20.5M $ | |
| 25 | Genmab A/S | 752,261 | 20.2M $ | |
| 26 | Arcus Biosciences Inc | 923,086 | 19.9M $ | |
| 27 | Stryker Corp | 44,480 | 14.6M $ | |
| 28 | AnaptysBio Inc | 248,253 | 13.8M $ | |
| 29 | Edgewise Therapeutics Inc | 386,498 | 12.2M $ | |
| 30 | Compass Therapeutics Inc | 2,056,161 | 10.9M $ | |
| 31 | ORIC Pharmaceuticals Inc | 679,578 | 8.6M $ | |
| 32 | Tango Therapeutics Inc | 395,081 | 8.3M $ | |
| 33 | Tyra Biosciences Inc | 204,015 | 7.8M $ | |
| 34 | Axogen Inc | 210,665 | 7M $ | |
| 35 | Cytokinetics Inc | 91,791 | 6M $ | |
| 36 | Disc Medicine Inc | 78,320 | 5M $ | |
| 37 | VeraDermics Inc | 73,315 | 4.6M $ | |
| 38 | Harmony Biosciences Holdings Inc | 152,695 | 4.3M $ | |
| 39 | Vaxcyte Inc | 50,600 | 2.9M $ | |
| 40 | Mirum Pharmaceuticals Inc | 27,591 | 2.5M $ | |
| 41 | NextCure Inc | 222,654 | 2.4M $ | |
| 42 | Savara Inc | 364,763 | 2M $ | |
| 43 | ACADIA Pharmaceuticals Inc | 78,551 | 1.7M $ | |
| 44 | Tenax Therapeutics Inc | 104,400 | 1.7M $ | |
| 45 | JADE BIOSCIENCES INC | 107,391 | 1.5M $ | |
| 46 | Septerna Inc | 47,506 | 1.1M $ | |
| 47 | OnKure Therapeutics Inc | 141,700 | 586.6K $ | |
| 48 | BOLT BIOTHERAPEUTICS INC | 137,721 | 556.4K $ | |
| 49 | Soleno Therapeutics Inc | 14,689 | 491.8K $ | |
| 50 | IMAGENEBIO INC | 31,884 | 159.4K $ | |
| 51 | Zymeworks Inc | 1,610 | 40.3K $ | |